glucagon has been researched along with amlodipine in 2 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (amlodipine) | Trials (amlodipine) | Recent Studies (post-2010) (amlodipine) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 4,200 | 1,504 | 1,671 |
Protein | Taxonomy | glucagon (IC50) | amlodipine (IC50) |
---|---|---|---|
Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 1.2 | |
Potassium channel subfamily K member 2 | Homo sapiens (human) | 0.4 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.602 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.8 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.898 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 5.521 | |
Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 2.7 | |
Potassium channel subfamily K member 2 | Bos taurus (cattle) | 0.43 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferguson, KL; Greller, HA; Hoffman, RS; Nelson, LS; Smith, SW | 1 |
Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T | 1 |
2 other study(ies) available for glucagon and amlodipine
Article | Year |
---|---|
Prolonged severe hypotension following combined amlodipine and valsartan ingestion.
Topics: Aged; Amlodipine; Antidotes; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Cardiac Catheterization; Drug Interactions; Drug Overdose; Female; Glucagon; Humans; Hypotension; Insulin; Naloxone; Severity of Illness Index; Suicide, Attempted; Tetrazoles; Time Factors; Valine; Valsartan | 2008 |
Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Glucagon; Glucose Transporter Type 1; Glycated Hemoglobin; Glycogen; Hypertension; Kidney; Male; Norepinephrine; Proteinuria; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2013 |